TY - JOUR
T1 - PET/MR Technology
T2 - Advancement and Challenges
AU - Bogdanovic, Borjana
AU - Solari, Esteban Lucas
AU - Villagran Asiares, Alberto
AU - McIntosh, Lachlan
AU - van Marwick, Sandra
AU - Schachoff, Sylvia
AU - Nekolla, Stephan G.
N1 - Publisher Copyright:
© 2021 Elsevier Inc.
PY - 2022/5
Y1 - 2022/5
N2 - When this article was written, it coincided with the 11th anniversary of the installation of our PET/MR device in Munich. In fact, this was the first fully integrated device to be in clinical use. During this time, we have observed many interesting behaviors, to put it kindly. However, it is more critical that in this process, our understanding of the system also improved - including the advantages and limitations from a technical, logistical, and medical perspective. The last decade of PET/MRI research has certainly been characterized by most sites looking for a "key application." There were many ideas in this context and before and after the devices became available, some of which were based on the earlier work with integrating data from single devices. These involved validating classical PET methods with MRI (eg, perfusion or oncology diagnostics). More important, however, were the scenarios where intermodal synergies could be expected. In this review, we look back on this decade-long journey, at the challenges overcome and those still to come.
AB - When this article was written, it coincided with the 11th anniversary of the installation of our PET/MR device in Munich. In fact, this was the first fully integrated device to be in clinical use. During this time, we have observed many interesting behaviors, to put it kindly. However, it is more critical that in this process, our understanding of the system also improved - including the advantages and limitations from a technical, logistical, and medical perspective. The last decade of PET/MRI research has certainly been characterized by most sites looking for a "key application." There were many ideas in this context and before and after the devices became available, some of which were based on the earlier work with integrating data from single devices. These involved validating classical PET methods with MRI (eg, perfusion or oncology diagnostics). More important, however, were the scenarios where intermodal synergies could be expected. In this review, we look back on this decade-long journey, at the challenges overcome and those still to come.
UR - https://www.scopus.com/pages/publications/85121906581
U2 - 10.1053/j.semnuclmed.2021.11.014
DO - 10.1053/j.semnuclmed.2021.11.014
M3 - Review article
C2 - 34969520
AN - SCOPUS:85121906581
SN - 0001-2998
VL - 52
SP - 340
EP - 355
JO - Seminars in Nuclear Medicine
JF - Seminars in Nuclear Medicine
IS - 3
ER -